3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Philadelphia Chromosome
2
Bronchiolitis Obliterans Syndrome
2
Translocation, Genetic
1
Recurrence
1
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
1
Pathologic Processes
1
Neoplasms by Histologic Type
1
Leukemia, Myeloid
1
Leukemia
1
Hematologic Diseases
1
Graft vs Host Disease
1
Bone Marrow Diseases
1
Interventions
selpercatinib
2
binimetinib
2
Crizotinib
2
ulixertinib
1
tremelimumab
1
trastuzumab biosimilar HLX02
1
trametinib
1
sapanisertib
1
repotrectinib
1
relatlimab
1
pralsetinib
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
encorafenib
1
durvalumab
1
defactinib
1
dabrafenib
1
copanlisib
1
ceritinib
1
capmatinib
1
capivasertib
1
brigatinib
1
adavosertib
1
X-Rays
1
Trastuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Lung Neoplasms
×
Imatinib Mesylate
×
Clear all
No trials found.